An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

The developers of OpenFold3 have released an early version of the tool, which they hope will one day perform on par with DeepMind’s protein-structure model.

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the-Madison suggest that problems with a key protein that helps ...

Every modern automobile carries a 17-character vehicle identification number, an alphanumeric string unique to that single ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

The Welsh Rugby Union (WRU) has announced a landmark decision on the future of elite rugby in Wales, following one of the ...

Spaceflight rewires the human body. Muscles shrink, bones thin and fluids shift towards the brain – but these changes may ...

Why Some People Are Born to Be Afraid Scientists are discovering that our tendency to develop certain phobias might be ...

Can artificial intelligence function as a partner in scientific discovery, capable of generating novel, testable hypotheses ...